跳至主要内容
临床试验/NCT02712697
NCT02712697Unknown不适用

Treatment of Shentong Granules Plus Prednisone on Patients With Severe IgA Nephropathy(Ying-deficiency of the Liver and Kidney Pattern): a Randomized, Double-blind,Placebo-controlled Multicentre Clinical Trial

Shanghai University of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
140
试验地点
1
主要终点
Glomerular filtration rate

研究概览

简要总结

The present study was designed to identify the efficacy and safety of Integrative Medicine by joint oral steroid medicine on liver-kidney yin deficiency, severe IgA nephropathy. Furthermore, search for potential diagnostic predictor in IgA Nephropathy by Proteomics and Metabolomics.

详细描述

The present study was designed to identify the efficacy and safety of Integrative Medicine by joint oral steroid medicine on liver-kidney yin deficiency, severe IgA nephropathy. Furthermore, search for potential diagnostic predictor in IgA Nephropathy by Proteomics and Metabolomics. Combined with TCM Syndrome research, the investigators will clarify targets or mechanisms of herbal treatment. Eventually, to form a more clinically appropriate standardized combination treatment of severe IgA nephropathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The primary IgAN was confirmed by renal biopsy and clinical examination, and the pathological manifestations were Lee's grade and above;
  • TCM is liver kidney yin deficiency syndrome;
  • age 18-70 years old, sex, nationality is not limited;
  • CKD phase 2-4 (89 ml/min>eGFR(EPI Formula)>15ml/min/1.73m2);
  • 24 hour urinary protein≥1g.

排除标准

  • It had received immunosuppressive drugs and cytotoxic therapy within the past 3 months more than 4 weeks;
  • It had received corticosteroids (prednisone or prednisolone) within the past 3 months more than 20mg/d for more than up to 4 weeks;
  • Acute or progressive glomerulonephritis patients;
  • Severe complications threat to life, such as severe infection;
  • Active hepatitis B and liver function test sustained abnormal;
  • Patients with malignant tumor or have a history of cancer, HIV infection, history of mental illness, acute central nervous system diseases, severe gastrointestinal diseases, prohibition of the use of hormone;
  • Abnormal glucose metabolism, fasting blood glucose over 6.2mmol/L;
  • Gravid or lactation woman;
  • Other clinical trials are being studied;
  • Merger with other serious disease and dysfunction of the organ.

研究组 & 干预措施

WM Group

Experimental

Shentong Granules, two packs, bid, P.O., 48weeks; Prednisone, 0.5-1mg/kg.d, P.O., eight to twelve weeks; then reduced to 30mg by reduce 5mg every two weeks; followed by the monthly reduction of 5mg, about 9-12 months

干预措施: WM (Shentong Granules) (Drug)

WM Group

Experimental

Shentong Granules, two packs, bid, P.O., 48weeks; Prednisone, 0.5-1mg/kg.d, P.O., eight to twelve weeks; then reduced to 30mg by reduce 5mg every two weeks; followed by the monthly reduction of 5mg, about 9-12 months

干预措施: Hormone (prednisone) (Drug)

Hormone Group

Placebo Comparator

Placebo ; Prednisone, 0.5-1mg/kg.d, P.O., eight to twelve weeks; then reduced to 30mg by reduce 5mg every two weeks; followed by the monthly reduction of 5mg, about 9-12 months

干预措施: Hormone (prednisone) (Drug)

结局指标

主要结局

Glomerular filtration rate

时间窗: changes from Baseline to 2, 4, 12, 24,36 and 48 weeks

次要结局

  • serum Lipid(Half-yearly)
  • 24-hour urinary protein excretion(changes from Baseline to 2, 4, 12, 24,36 and 48 weeks)
  • serum creatinine(changes from Baseline to 2, 4, 12, 24,36 and 48 weeks)
  • TCM syndrome score(changes from Baseline to 2, 4, 12, 24,36 and 48 weeks)

研究者

发起方
Shanghai University of Traditional Chinese Medicine
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验